Your Notifications
All done, no notifications

About Dr. Professor Ke Xiaoyan

  • Professor Ke Xiaoyan is a senior haematology specialist and Professor in the Department of Lymphoma and Myeloma, with extensive expertise in the precision diagnosis and treatment of lymphoma and other hematologic malignancies.
  • She is widely recognised for integrating next-generation gene sequencing, targeted therapies, CAR-T therapy, chemotherapy, and stem cell transplantation to improve outcomes in relapsed and refractory cases.
  • She has recognised as one of the leading experts in lymphoma research and treatment in China
  • She has played a key role in promoting the WHO lymphoma classification in China
  • She has led and participated in multiple national and multi-centre research projects on lymphoma diagnosis and treatment

Conditions treated byProfessor Ke Xiaoyan

  • Lymphoma (including relapsed and refractory lymphoma)
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • MALT-type Extranodal Marginal Zone B-Cell Lymphoma
  • T-cell and NK-cell lymphoma
  • Leukemia
  • Multiple myeloma
  • Other hematologic malignancies

Area of Interest

  • Precision treatment of lymphoma using next-generation gene sequencing
  • Chemotherapy combined with targeted therapy and immunotherapy
  • CAR-T therapy for relapsed and refractory lymphoma
  • High-dose chemotherapy and autologous stem cell transplantation
  • Minimal residual disease (MRD) monitoring
  • Standardisation of lymphoma diagnosis and treatment
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Ke Xiaoyan on our platform

MEMBERSHIPS (9)

  • Executive Director, Chinese Women Physicians Association
  • Director, Targeted Therapy Branch, Chinese Women Physicians Association
  • Honorary Chairman, Haematology Society
  • Deputy Chairman, Haematology Professional Committee, Chinese Medical Education Association
  • Member, Chinese Society of Experimental Haematology
  • Associate Editor, Leukaemia & Lymphoma Journal
  • Editorial Board Member for multiple haematology and oncology journals
  • Expert for Central Health Care Consultations
  • Consultant, Ministry of Health and Beijing Medical Technology Evaluation

Share Your Experience about Dr. Professor Ke Xiaoyan

PROCEDURES

  • CAR-T

FREQUENTLY ASKED QUESTIONS

Is Professor Ke Xiaoyan doing teleconsultation on the MediGence platform?
Professor Ke Xiaoyan is available to teleconsult on the MediGence platform.
How long is the consultation?
The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
How soon can the consultation be organised?
We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the doctor's and the patient's availability.
Is a follow-up consultation included in the consultation price?
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
How do I share my medical record with the doctor for review?
The option to share your medical records is available at the steps of the form provided on the website.
Can I book my procedure with the doctor after the consultation?
Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.
Can you get an estimate for the procedure?
Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Hemato Oncologist

What is a haematologist?
A haematologist is a medical doctor specialising in diagnosing, treating, and managing diseases related to the blood, bone marrow, and lymphatic system. This includes anaemia, clotting disorders, leukaemia, lymphoma, and more.
When should I see a haematologist?
You may be referred to a haematologist if you have:
What conditions does a haematologist treat?
Haematologists commonly treat:
What tests might a haematologist order?
Depending on your symptoms, a haematologist may request:
What treatments do haematologists offer?
Treatments can include:
Is seeing a haematologist the same as seeing an oncologist?
Not always. While some haematologists are also trained in oncology (cancer treatment), not all blood disorders are cancer-related. Some haematologists focus on non-cancerous blood conditions like anaemia or clotting disorders, while others also treat blood cancers.

Reviewer

Dr. Abdullah Rahil

MPT (Neuro)

5 Years of Experience

Dr. Abdullah Rahil, M.P.T. (Neurology), served as a Senior Physiotherapist at VIAN Physiotherapy Clinic, Noida (2019-2023), specializing in orthopedic, neurological, and musculoskeletal rehabilitation. Skilled in dry needling, cupping, kinesiology taping, and manual therapy, he managed diverse cases and mentored junior physiotherapists. View More

Author

Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication.. View More